Yahoo Web Search

Search results

    • Is CRISPR Therapeutics Stock a Buy?

      Is CRISPR Therapeutics Stock a Buy?

      Motley Fool via Yahoo Finance· 50 minutes ago

      With the large-cap biotech taking the lead on commercializing it, Casgevy has been approved in the U.S., Great Britain, the European Union, Saudi Arabia...